Krishna Institute of Medical Sciences Limited has intimated the National Stock Exchange of India Limited and BSE Limited about scheduled one-on-one meetings with analysts or institutional investors. The meetings are scheduled to be held on June 4, 2026, and may be conducted through calls, video conference, or in-person meetings.
The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations. The company explicitly states that during these meetings, no unpublished price sensitive information (UPSI) shall be disclosed that is not already available in the public domain. All discussions will be based on the general business outlook and information that is already publicly available.
The company notes that the schedule may undergo changes due to exigencies on the part of investors or the company itself. The communication was digitally signed by Nagajayanthi J. R, who serves as Company Secretary and Compliance Officer, on June 1, 2026, at 19:54:24 +05:30.